title: Fotemustine and tamoxifen combination therapy in metastatic malignant melanoma. A phase II study.
authors.forename: C J
authors.initials: CJ
authors.lastname: Punt
authors.forename: J H
authors.initials: JH
authors.lastname: Tytgat
authors.forename: P A
authors.initials: PA
authors.lastname: van Liessum
authors.forename: B
authors.initials: B
authors.lastname: Gerard
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000556:secondary*; D008875:Middle Aged; D009607:Nitrosourea Compounds / Q000008:administration & dosage; D009943:Organophosphorus Compounds / Q000008:administration & dosage; D013629:Tamoxifen / Q000008:administration & dosage
chemical_list: D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D009943:Organophosphorus Compounds; D013629:Tamoxifen; C054368:fotemustine